Related Experiment Videos

[Hypertension in the elderly]

Pierre-François Plouin1, Patrick Rossignol, Guillaume Bobrie

  • 1Unité d'hypertension artérielle, Hôpital Européen Georges Pompidou, 75908 Paris 15.

Bulletin De L'Academie Nationale De Medecine
|January 2, 2007
PubMed

Insights

Systolic hypertension is common in older adults and increases cardiovascular risk. Current treatments often fail to adequately control systolic blood pressure, compromising prevention of heart attacks and strokes.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Systolic blood pressure (SBP) increases with age, with hypertension prevalence exceeding 70% in individuals over 70.
  • Elevated SBP is a significant risk factor for cardiovascular death, stroke, and myocardial infarction across all age groups.
  • Antihypertensive medications are effective in reducing cardiovascular mortality and morbidity for SBP above 160 mmHg.

Purpose of the Study:

  • To examine the challenges in achieving adequate systolic blood pressure control in elderly hypertensive patients.
  • To identify factors contributing to the limited efficacy of blood pressure reduction in preventing cardiovascular events in this population.

Main Methods:

  • Review of existing literature on systolic hypertension in the elderly.
  • Analysis of factors influencing antihypertensive medication efficacy.
  • Assessment of physician adherence to treatment guidelines for systolic hypertension.

Main Results:

  • Blood pressure reduction efficacy is often limited in elderly hypertensive patients.
  • Poor systolic blood pressure control frequently compromises the prevention of cardiovascular events.
  • Physician non-adherence to established treatment guidelines contributes to suboptimal systolic hypertension management.

Conclusions:

  • Effective management of systolic hypertension in the elderly remains a significant clinical challenge.
  • Improving treatment adherence and exploring more efficacious therapeutic strategies are crucial for reducing cardiovascular risk in older adults.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...